International Olympic Committee consensus statement: molecular basis of connective tissue and muscle injuries in sport.
Tendon and ligament injures cause significant loss of performance in sport and decreased functional capacity in the workplace. Many of these injures remain difficult to treat, and many individuals have long-term pain and discomfort. Animal studies of growth factor and cell-based therapies have shown promising results, but these treatments also can be misused to enhance athletic performance. The International Olympic Committee (IOC) now has high-level scientific advisors who can advise the IOC as to the use and abuse of these technologies.
Ljungqvist
Arne
A
International Olympic Committee Medical Commission, Lausanne, Switzerland.
Schwellnus
Martin P
MP
Bachl
Norbert
N
Collins
Malcolm
M
Cook
J
J
Khan
K M
KM
Maffulli
Nicola
N
Pitsiladis
Y
Y
Riley
G
G
Golspink
G
G
Venter
D
D
Derman
E W
EW
Engebretsen
L
L
Volpi
P
P
D003238:Connective Tissue / Q000293:injuries*; D004300:Doping in Sports; D020022:Genetic Predisposition to Disease; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000009:adverse effects; D045164:Mesenchymal Stem Cell Transplantation; D018482:Muscle, Skeletal / Q000293:injuries*; D017695:Soft Tissue Injuries / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D013710:Tendons / Q000033:anatomy & histology / Q000502:physiology; D016474:Weight-Bearing / Q000502:physiology
D036341:Intercellular Signaling Peptides and Proteins